Immunitoai
2 known investors
immunitoAI develops AI-generated antibody therapeutics designed with predefined drug properties for any protein target. The company uses computational methods to design novel antibodies in silico, enabling faster drug development for therapeutic applications.
AI & Machine LearningBiotechMedical Devices